1. Home
  2. CYN vs CTSO Comparison

CYN vs CTSO Comparison

Compare CYN & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cyngn Inc.

CYN

Cyngn Inc.

HOLD

Current Price

$1.23

Market Cap

22.9M

Sector

Technology

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.46

Market Cap

26.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYN
CTSO
Founded
2013
1997
Country
United States
United States
Employees
62
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9M
26.5M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
CYN
CTSO
Price
$1.23
$0.46
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
197.7K
209.1K
Earning Date
05-06-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.79
EPS
N/A
N/A
Revenue
$368,138.00
$22,503,908.00
Revenue This Year
$3,359.28
$10.34
Revenue Next Year
$347.47
$22.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.53
52 Week Low
$1.22
$0.37
52 Week High
$41.54
$1.39

Technical Indicators

Market Signals
Indicator
CYN
CTSO
Relative Strength Index (RSI) 39.76 45.56
Support Level N/A $0.37
Resistance Level $1.76 $0.72
Average True Range (ATR) 0.08 0.06
MACD -0.00 0.01
Stochastic Oscillator 27.54 35.57

Price Performance

Historical Comparison
CYN
CTSO

About CYN Cyngn Inc.

Cyngn Inc is an industrial autonomous vehicle technology company, focused on addressing industrial uses for autonomous vehicles. It develops full-stack autonomous driving software, DriveMod, which is integrated into vehicles manufactured by original equipment manufacturers during the assembly process. The company designs its software to be compatible with a range of sensors and hardware components and integrates it with its own systems to enable autonomous vehicle functionality.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: